vs
CANTALOUPE, INC.（CTLP）与湘南美容医疗集团（SBC）财务数据对比。点击上方公司名可切换其他公司
CANTALOUPE, INC.的季度营收约是湘南美容医疗集团的2.0倍（$78.7M vs $39.6M），湘南美容医疗集团净利率更高（35.9% vs -0.1%，领先36.0%），CANTALOUPE, INC.同比增速更快（6.8% vs -10.9%），湘南美容医疗集团自由现金流更多（$51.2M vs $-614.0K），过去两年CANTALOUPE, INC.的营收复合增速更高（7.7% vs -15.0%）
坎塔卢波（原美国技术公司）是一家美国科技企业，核心业务为ePort无现金支付受理技术，依托持专利的PCI合规ePort Connect服务开展运营。该服务可通过无线方式为消费者提供信用卡、借记卡以及Apple Pay、Google Pay等NFC钱包支付选项，同时为运营商提供遥测与机器间通信服务，ePort技术主要应用于...
湘南美容医疗集团是总部位于日本的知名医疗服务提供商，核心业务覆盖美容整形、皮肤科诊疗、抗衰老健康护理等领域，在日本各地运营大量连锁诊所，同时服务本地居民及赴日就医的国际游客。
CTLP vs SBC — 直观对比
营收规模更大
CTLP
是对方的2.0倍
$39.6M
营收增速更快
CTLP
高出17.7%
-10.9%
净利率更高
SBC
高出36.0%
-0.1%
自由现金流更多
SBC
多$51.8M
$-614.0K
两年增速更快
CTLP
近两年复合增速
-15.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $78.7M | $39.6M |
| 净利润 | $-70.0K | $14.2M |
| 毛利率 | — | 73.1% |
| 营业利润率 | 2.0% | 32.5% |
| 净利率 | -0.1% | 35.9% |
| 营收同比 | 6.8% | -10.9% |
| 净利润同比 | -101.4% | 117.2% |
| 每股收益（稀释后） | $0.00 | $0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTLPSBC
| Q4 25 | $78.7M | $39.6M | ||
| Q3 25 | $80.9M | $43.4M | ||
| Q2 25 | $82.6M | $43.4M | ||
| Q1 25 | $75.4M | $47.3M | ||
| Q4 24 | $73.7M | $44.4M | ||
| Q3 24 | $70.8M | $53.1M | ||
| Q2 24 | $72.7M | $53.1M | ||
| Q1 24 | $67.9M | $54.8M |
净利润CTLPSBC
| Q4 25 | $-70.0K | $14.2M | ||
| Q3 25 | $-919.0K | $12.8M | ||
| Q2 25 | $6.8M | $2.5M | ||
| Q1 25 | $49.2M | $21.5M | ||
| Q4 24 | $5.0M | $6.5M | ||
| Q3 24 | $3.6M | $2.8M | ||
| Q2 24 | $2.2M | $18.5M | ||
| Q1 24 | $4.7M | $18.8M |
毛利率CTLPSBC
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | 39.6% | 72.1% |
营业利润率CTLPSBC
| Q4 25 | 2.0% | 32.5% | ||
| Q3 25 | 2.0% | 36.6% | ||
| Q2 25 | 6.3% | 33.6% | ||
| Q1 25 | 9.1% | 51.1% | ||
| Q4 24 | 8.4% | 10.6% | ||
| Q3 24 | 5.8% | 26.1% | ||
| Q2 24 | 4.9% | 51.4% | ||
| Q1 24 | 6.3% | 44.6% |
净利率CTLPSBC
| Q4 25 | -0.1% | 35.9% | ||
| Q3 25 | -1.1% | 29.6% | ||
| Q2 25 | 8.3% | 5.7% | ||
| Q1 25 | 65.2% | 45.4% | ||
| Q4 24 | 6.7% | 14.7% | ||
| Q3 24 | 5.0% | 5.3% | ||
| Q2 24 | 3.0% | 34.8% | ||
| Q1 24 | 6.9% | 34.2% |
每股收益（稀释后）CTLPSBC
| Q4 25 | $0.00 | $0.15 | ||
| Q3 25 | $-0.02 | $0.12 | ||
| Q2 25 | $0.10 | $0.02 | ||
| Q1 25 | $0.65 | $0.21 | ||
| Q4 24 | $0.07 | $0.05 | ||
| Q3 24 | $0.04 | $0.03 | ||
| Q2 24 | $0.03 | $0.20 | ||
| Q1 24 | $0.06 | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $53.0M | $164.1M |
| 总债务越低越好 | $37.7M | $42.8M |
| 股东权益账面价值 | $252.5M | $248.3M |
| 总资产 | $381.9M | $380.4M |
| 负债/权益比越低杠杆越低 | 0.15× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CTLPSBC
| Q4 25 | $53.0M | $164.1M | ||
| Q3 25 | $55.0M | $127.4M | ||
| Q2 25 | $51.1M | $152.7M | ||
| Q1 25 | $46.3M | $132.1M | ||
| Q4 24 | $27.7M | $125.0M | ||
| Q3 24 | $33.1M | $137.4M | ||
| Q2 24 | $58.9M | — | ||
| Q1 24 | $50.2M | — |
总债务CTLPSBC
| Q4 25 | $37.7M | $42.8M | ||
| Q3 25 | $38.3M | $21.1M | ||
| Q2 25 | $38.7M | $7.1M | ||
| Q1 25 | $39.2M | $6.9M | ||
| Q4 24 | $37.0M | $6.6M | ||
| Q3 24 | $37.3M | $823.2K | ||
| Q2 24 | $37.5M | — | ||
| Q1 24 | $38.1M | — |
股东权益CTLPSBC
| Q4 25 | $252.5M | $248.3M | ||
| Q3 25 | $251.8M | $248.0M | ||
| Q2 25 | $251.0M | $244.6M | ||
| Q1 25 | $240.7M | $226.4M | ||
| Q4 24 | $190.1M | $195.1M | ||
| Q3 24 | $186.2M | $205.0M | ||
| Q2 24 | $181.7M | $8.8M | ||
| Q1 24 | $178.8M | $9.0M |
总资产CTLPSBC
| Q4 25 | $381.9M | $380.4M | ||
| Q3 25 | $389.5M | $321.4M | ||
| Q2 25 | $381.9M | $315.3M | ||
| Q1 25 | $370.5M | $284.6M | ||
| Q4 24 | $303.0M | $266.1M | ||
| Q3 24 | $312.1M | $296.5M | ||
| Q2 24 | $335.6M | $19.5M | ||
| Q1 24 | $319.9M | $19.8M |
负债/权益比CTLPSBC
| Q4 25 | 0.15× | 0.17× | ||
| Q3 25 | 0.15× | 0.09× | ||
| Q2 25 | 0.15× | 0.03× | ||
| Q1 25 | 0.16× | 0.03× | ||
| Q4 24 | 0.19× | 0.03× | ||
| Q3 24 | 0.20× | 0.00× | ||
| Q2 24 | 0.21× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.1M | $52.0M |
| 自由现金流经营现金流 - 资本支出 | $-614.0K | $51.2M |
| 自由现金流率自由现金流/营收 | -0.8% | 129.3% |
| 资本支出强度资本支出/营收 | 4.8% | 2.0% |
| 现金转化率经营现金流/净利润 | — | 3.66× |
| 过去12个月自由现金流最近4个季度 | $25.8M | $23.3M |
8季度趋势，按日历期对齐
经营现金流CTLPSBC
| Q4 25 | $3.1M | $52.0M | ||
| Q3 25 | $7.0M | $-20.9M | ||
| Q2 25 | $9.4M | $-8.3M | ||
| Q1 25 | $22.4M | $1.9M | ||
| Q4 24 | $522.0K | $-7.3M | ||
| Q3 24 | $-12.0M | $5.0M | ||
| Q2 24 | $14.3M | $19.2M | ||
| Q1 24 | $14.7M | $3.7M |
自由现金流CTLPSBC
| Q4 25 | $-614.0K | $51.2M | ||
| Q3 25 | $3.5M | $-20.9M | ||
| Q2 25 | $4.3M | $-8.6M | ||
| Q1 25 | $18.6M | $1.7M | ||
| Q4 24 | $-3.8M | $-7.9M | ||
| Q3 24 | $-15.8M | $4.6M | ||
| Q2 24 | $8.5M | $18.3M | ||
| Q1 24 | $11.4M | $3.0M |
自由现金流率CTLPSBC
| Q4 25 | -0.8% | 129.3% | ||
| Q3 25 | 4.4% | -48.3% | ||
| Q2 25 | 5.3% | -19.9% | ||
| Q1 25 | 24.6% | 3.5% | ||
| Q4 24 | -5.1% | -17.8% | ||
| Q3 24 | -22.3% | 8.7% | ||
| Q2 24 | 11.7% | 34.5% | ||
| Q1 24 | 16.9% | 5.4% |
资本支出强度CTLPSBC
| Q4 25 | 4.8% | 2.0% | ||
| Q3 25 | 4.2% | 0.1% | ||
| Q2 25 | 6.2% | 0.7% | ||
| Q1 25 | 5.1% | 0.5% | ||
| Q4 24 | 5.8% | 1.3% | ||
| Q3 24 | 5.4% | 0.8% | ||
| Q2 24 | 7.9% | 1.6% | ||
| Q1 24 | 4.8% | 1.3% |
现金转化率CTLPSBC
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | 1.38× | -3.39× | ||
| Q1 25 | 0.46× | 0.09× | ||
| Q4 24 | 0.10× | -1.12× | ||
| Q3 24 | -3.36× | 1.77× | ||
| Q2 24 | 6.47× | 1.04× | ||
| Q1 24 | 3.16× | 0.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTLP
| Transaction Processing | $47.9M | 61% |
| Subscription Revenue | $21.8M | 28% |
| Products | $9.0M | 11% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
